Olomax Tablet 40/5/10 mg (Olmesartan medoxomil, Amlodipine, Rosuvastatin)

Adult dose

This medication is administered as one tablet once a day with water, regardless of meals. It is recommended to take it at the same time each day (e.g., morning) if possible. The recommended dosage of Olmesartan medoxomil/Amlodipine combination is as follows: - 20/5 mg: for patients whose blood pressure is not controlled with monotherapy - 40/5 mg: for patients whose blood pressure is not controlled with 20/5 mg - 40/10 mg

This medication can cause serious harm to the fetus and newborn, especially during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients allergic to the active ingredients of this medication or similar medications, pregnant or breastfeeding women, patients with severely impaired liver or kidney function, and patients with specific heart diseases should not take this medication. Patients who are deficient in fluids or salts may experience hypotension when taking this medication, thus their condition should be carefully monitored, and appropriate measures taken if hypotension occurs. Patients with heart valve disease should be especially cautious, as rapid vasodilation can lead to hypotension. Patients with coronary artery disease or heart failure may experience worsened cardiac conditions when taking this medication, so it should be taken carefully under a doctor’s instruction. Patients with impaired renal function or kidney transplant patients should regularly check their kidney function and serum electrolyte levels before and during treatment with this medication. Patients with liver dysfunction may be affected by the metabolism and action of this medication, necessitating dose adjustment and monitoring. This medication may increase serum potassium levels, so patients at risk for hyperkalemia should periodically check their serum potassium levels. If symptoms of muscle pain or weakness occur, inform a doctor immediately and undergo necessary tests, and discontinue the medication if severe. This medication may cause side effects such as liver function abnormalities, gastrointestinal disorders, headache, dizziness, and edema in some patients, so consult healthcare professionals if symptoms persist or worsen. There may be interactions when used in combination with other medications, so if other drugs are being taken, it is important to inform healthcare professionals, especially when used with potassium-sparing diuretics, lithium, or non-steroidal anti-inflammatory drugs. Taking this medication with grapefruit juice may increase its serum concentration, so it is recommended to avoid grapefruit juice consumption. Special care is not specifically required during driving or operating machinery, but caution should be exercised if symptoms such as dizziness occur.

Serious side effects

Urticaria, angioedema, subarachnoid hemorrhage, increased ALT, increased AST, severe allergic reactions, hyperkalemia, hematuria, jaundice, hepatitis, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, immune-mediated necrotizing myopathy, acute renal failure, anuria, thrombocytopenia, increased serum creatinine, multiple organ dysfunction syndrome, viral pneumonia, cardiac sudden death, acute myocardial infarction,

Mild side effects

• Palpitations
• upper abdominal pain
• vomiting
• fatigue
• peripheral edema
• bacterial pneumonia
• hypoglycemia
• dizziness
• headache
• hematuria

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. Storing it this way can help maintain the efficacy and safety of the medication.

Appearance

Light pink round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle